Skyepharma Plc (SKYEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 06-2015 | 12-2014 | 06-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 62,840 | 42,270 | 53,390 | 44,260 | 25,810 |
| Marketable Securities | 150 | 0 | 0 | 0 | 0 |
| Receivables | 22,780 | 22,510 | 24,060 | 31,130 | 21,120 |
| Inventories | 14,210 | 19,750 | 17,140 | 18,680 | 13,770 |
| Other current assets | 10 | 2,460 | 3,300 | 4,210 | 3,140 |
| TOTAL | $99,990 | $86,990 | $97,890 | $98,280 | $63,840 |
| Non-Current Assets | |||||
| Investments And Advances | 610 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 19,090 | 17,590 | 16,470 | 9,590 | 8,290 |
| TOTAL | $19,700 | $17,590 | $16,470 | $9,590 | $8,290 |
| Total Assets | $157,790 | $136,770 | $149,970 | $152,980 | $116,730 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 45,870 | 44,560 | 48,280 | 40,220 | 35,050 |
| Accrued Expenses | 6,420 | 0 | 0 | 0 | 0 |
| Other current liabilities | 3,360 | 5,050 | 6,750 | 3,020 | 2,030 |
| TOTAL | $58,100 | $52,380 | $64,270 | $57,890 | $52,420 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,330 | 7,500 | 19,440 | 34,500 | 142,240 |
| Other Non-Current Liabilities | 10,090 | 10,720 | 10,050 | 6,900 | 6,570 |
| TOTAL | $23,380 | $28,480 | $40,860 | $57,050 | $165,390 |
| Total Liabilities | $81,490 | $80,860 | $105,140 | $114,940 | $217,820 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 104,812 | N/A | N/A | N/A | N/A |
| Common Shares | 274,300 | 274,760 | 295,660 | 301,930 | 188,870 |
| Retained earnings | -779,330 | -818,640 | -894,580 | -922,620 | -830,590 |
| Other shareholders' equity | -41,280 | -23,880 | -27,360 | -26,590 | -25,340 |
| TOTAL | $76,290 | $55,900 | $44,820 | $38,030 | $-101,080 |
| Total Liabilities And Equity | $157,780 | $136,760 | $149,960 | $152,970 | $116,740 |